Pluristem Granted Patent in Singapore for Its 3D Cell Expansion Technology
Pluristem Therapeutics Inc., a leading developer of placenta-based cell therapy products, announced today it has been granted a patent in Singapore titled "Methods for Cell Expansion and Uses of Cells and Conditioned Media Produced Thereby for Therapy."
View full press release